← Back to Search

Psychosocial Support for Cardiomyopathy

N/A
Recruiting
Led By Jim Cheung, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All patients with documented diagnosis of Takotsubo Syndrome greater than 18 years old.
Be older than 18 years old
Must not have
Patients with a diagnosis of Takotsubo Syndrome already undergoing Psychotherapy or those who choose not to participate
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, one year
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if joining a virtual support group helps reduce anxiety symptoms over one year.

Who is the study for?
This trial is for adults over 18 with a confirmed diagnosis of Takotsubo Syndrome, which is a type of heart condition. It's not open to those already in psychotherapy, non-English speakers, prisoners, pregnant women, or anyone unable to consent.
What is being tested?
The trial is testing if joining a virtual support group can reduce anxiety among people with Takotsubo Syndrome after one year compared to those who don't participate in the group.
What are the potential side effects?
Since this intervention involves psychosocial support rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort during discussions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 and have been diagnosed with Takotsubo Syndrome.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have Takotsubo Syndrome and am either in psychotherapy or choose not to participate.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, one year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in anxiety level as measured by the STAI.
Secondary study objectives
Changes in depression as measured by the PHQ-8.
Changes in quality of life as measured by the KCCQ.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Takotsubo Support GroupExperimental Treatment1 Intervention
Participants diagnosed with Takotsubo Syndrome will be enrolled into the study.

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,092 Previous Clinical Trials
1,154,762 Total Patients Enrolled
Jim Cheung, MDPrincipal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
128 Total Patients Enrolled

Media Library

Takotsubo Support Group Clinical Trial Eligibility Overview. Trial Name: NCT05977049 — N/A
Broken Heart Syndrome Research Study Groups: Takotsubo Support Group
Broken Heart Syndrome Clinical Trial 2023: Takotsubo Support Group Highlights & Side Effects. Trial Name: NCT05977049 — N/A
Takotsubo Support Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05977049 — N/A
~16 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top